Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors
Author(s): Christina Magnussen Added: 9 months ago
ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global… View more

Cardiovascular Renal Metabolic
GLP-1 RAs in T2D and Established or High-risk ASCVD
Author(s): Wanwarang Wongcharoen , Rungroj Krittayaphong , Wacin Buddhari , et al Added: 8 months ago

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
Risk Prediction of CVD in the Asia-Pacific Region
Author(s): SCORE2 Asia-Pacific Writing Group , Steven HJ Hageman , Zijuan Huang , et al Added: 1 year ago

Demographic

Heart Failure
Undetectable hs-TnI Serves as a De-risking Marker
Author(s): Phattararuethai Sabkaewyod , Prin Vathesatogkit , Piyamitr Sritara Added: 1 year ago

Prevention & Chronic Conditions
EASD 23: Epidemiologic Trends & Disparities in Diabetes Risk Among LGBTQ+ Population
Author(s): Carl Streed Added: 2 years ago
EASD 2023 – Dr Carl G Streed (Boston University School of Medicine, US) joins us to summarise healthcare disparities among the LGBTQ+ population.In this interview, Dr Streed discusses the available evidence and explains the minority stress model. This model suggests that experiences of discrimination and stress contribute to worse health outcomes in the LGBTQ community. This can lead to mental… View more

Demographic

Prevention & Chronic Conditions
Hospital Frailty Risk Score in Heart Failure
Author(s): Zhenwei Teo , Ying Zi Oh , Weiliang Huang , et al Added: 1 year ago

Guidelines & Statements

Heart Failure
Heart Disease in Pregnancy: Maternal and Neonatal Risk
Author(s): Rofila Dita Karmia , Mefri Yanni , Yusrawati , et al Added: 1 month ago

Electrophysiology & Arrhythmia

Heart Failure
EHRA 24: Insights from an ARTESiA Substudy
Author(s): William McIntyre Added: 1 year ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk… View more

Electrophysiology & Arrhythmia
Hypertension and Abnormal Renal Function in Type-1 EHRA Valvular AF
Author(s): Rena Winant , Sunu Budhi Raharjo , Rina Ariani , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Characteristics and Outcomes of Patients Undergoing RotaTripsy
Author(s): Paul Jie Wen Tern , Yann Shan Keh , Yee How Lau , et al Added: 1 year ago

Intervention

Vascular Disease and Surgery